To compare the efficacy of pulsed field ablation (PFA) versus medical therapy alone for the treatment of atrial fibrillation (AF), highlighting the significance of this comparison in clinical practice.
Key Findings:
PFA showed significantly lower readmission rates at 1 month (3.2% vs. 12.9%) and 6 months (4.8% vs. 17.7%) compared to medical therapy (p < 0.05), analyzed using appropriate statistical methods.
Kaplan–Meier analysis indicated higher freedom from readmission rates in the PFA cohort (92% vs. 69%; log-rank p = 0.002).
Interpretation:
The findings support the efficacy of PFA as a treatment for AF, aligning with global consensus and existing literature on the subject.
Limitations:
The study is retrospective and based on a single-center experience, which may introduce biases.
The sample size is relatively small, limiting generalizability.
Conclusion:
This early report from the MENA region lays the foundation for future larger studies to investigate PFA in this specific population, emphasizing the need for further validation.
